More than half a million Europeans suffer from disorders in or serious defects of some part of their bone structure. So, graft or implant operations needed to repair the damage depend decisively on the materials used. The Nanobiocom project, funded under the EU's Sixth Framework Programme (FP6), is working on the regeneration and repair of bone tissue.

The Commission has requested the advice of the Scientific Committee on Emerging and Newly Identified Health risks (SCENIHR) on the assessment of the antibiotic resistance effects of biocides. To ensure that the SCENIHR formulates its views on the basis of the most complete relevant information, the Commission has published a call for the submission of information regarding quantities of biocides used in various applications and regarding possible changes in microbial flora.

ecancermedicalscience aims to improve communications between sub-specialised cancer scientists and clinicians by working interactively and faster - offering authors a rapid peer review process. Submit your paper and you'll hear if it will be published within three weeks.

Nature Publishing Group (NPG) and Sermo, the largest online physician community in the US, announced a partnership to facilitate the discussion and interpretation of content in leading NPG medical journals by US physicians.

Collexis Holdings, Inc. (OTCBB: CLXS), a leading developer of high definition search and knowledge discovery software, announced the debut of BioMedExperts - the first online social network of its kind to improve collaboration among researchers and therefore advance medical science. Collexis launched the new service with more than 1.4 million pre-generated profiles of its expected users from across 120 countries and expects to grow by another two million profiles over the next few months.

DG Enterprise and Industry wishes to consult stakeholders on legislative proposals to strengthen and rationalise the EU system of pharmacovigilance. The Commission services conducted a previous consultation, between 16 March 2006 and 12 May 2006, which sought stakeholders' views on the strengths and weaknesses of the current EU system of pharmacovigilance and how the system could be strengthened.

Oil-for-food: UK probe to cover more companies
A UK government probe into whether GlaxoSmithKline, AstraZeneca and Eli Lilly & Co bribed the Saddam Hussein administration in Iraq may expand to other...

British ask Lilly for data on Iraq sales
British fraud investigators are questioning Eli Lilly and Co. and at least two other drug makers about possible kickbacks they paid to trade...

UK pulls Glaxo into Iraq fraud probe
Serious Fraud Office has requested documents from GlaxoSmithKline as part of an investigation into kickbacks or bribes that may have...